Artivion (AORT) SVP files Form 4: 10,000-option exercise, sale at $46.18

Artivion (AORT) insider activity: The company’s SVP and General Counsel reported multiple transactions.

Rhea-AI Filing Summary

Artivion (AORT) insider activity: The company’s SVP and General Counsel reported multiple transactions. On 11/10/2025, 2,960 shares of common stock were sold at $44.619 to cover tax withholding upon RSU vesting. On 11/11/2025, the insider exercised 10,000 stock options at an exercise price of $11.03 (code M) and sold 10,000 shares at $46.18. Following these transactions, the insider directly held 169,169 common shares.

The option exercised was originally granted with vesting at 33 1/3% per year beginning on 11/08/2023 and had an expiration date of 11/08/2029.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Holloway Jean F

Role SVP, General Counsel

Sold 12,960 shs ($594K)

Approx. gross sale proceeds $594K

Approx. exercise cost $110K

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to buy)	10,000	$0.00	$0.00
Exercise	Common Stock	10,000	$11.03	$110K
Sale	Common Stock	10,000	$46.18	$462K
Sale	Common Stock	2,960	$44.619	$132K

Holdings After Transaction: Stock Options (Right to buy) — 0 contracts (Direct); Common Stock — 169,169 shares (Direct)

Footnotes (2)

1. F1. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction
2. F2. Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AORT’s insider report on Form 4?

The SVP/General Counsel reported a tax-related sale of 2,960 shares at $44.619 on 11/10/2025, an exercise of 10,000 options at $11.03 on 11/11/2025, and a sale of 10,000 shares at $46.18 on 11/11/2025.

How many AORT shares does the insider own after the transactions?

The insider directly holds 169,169 common shares after the reported transactions.

What was the purpose of the 2,960-share sale on 11/10/2025?

It was a sell-to-cover transaction to satisfy tax withholding obligations upon RSU vesting.

What were the terms of the exercised AORT stock options?

The options covered 10,000 shares at an exercise price of $11.03, vesting 33 1/3% per year beginning 11/08/2023, with an expiration of 11/08/2029.

What is the reporting person’s role at Artivion (AORT)?

The reporting person is an Officer, serving as SVP, General Counsel.

Were the post-exercise shares sold?

Yes. On 11/11/2025, 10,000 shares were sold at $46.18 following the option exercise the same day.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 08:12 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Holloway Jean F

(Last) (First) (Middle)

1655 ROBERTS BLVD., NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2025		S		2,960(1)	D	$44.619	169,169	D
Common Stock	11/11/2025		M		10,000	A	$11.03	179,169	D
Common Stock	11/11/2025		S		10,000	D	$46.18	169,169	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	$11.03	11/11/2025		M			10,000	11/08/2023(2)	11/08/2029	Common Stock	10,000	$0	0	D

Explanation of Responses:

1. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction

2. Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

Remarks:

	/s/ Jean F Holloway	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.